A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine
Clinical trial NCT02776761 · COMPLETED
Trial details
- NCT number
- NCT02776761
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2017-09-27
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.